Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.67 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.67 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.67 |
| ▸ | CA12 | O43570 | 6/20 | 0.62 |
| ▸ | CA2 | P00918 | 6/20 | 0.62 |
| ▸ | PKM | P14618 | 1/20 | 0.59 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.59 |
| ▸ | CA9 | Q16790 | 5/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.58 |
| ▸ | MPO | P05164 | 6/20 | 0.56 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.53 |
| ▸ | NOX4 | Q9NPH5 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6366958 | 0.98 | TSHR (0.64) | TSHRHIF1ACYP2D6CA12CA2 | |
| SCHEMBL3200193 | 0.85 | CA12 (0.69) | TSHRHIF1ACYP2D6CA12CA2 | |
| SCHEMBL4783666 | 0.83 | TSHR (0.64) | TSHRHIF1ACYP2D6CA12CA2 | |
| SCHEMBL6366954 | 0.81 | TSHR (0.62) | TSHRHIF1ACYP2D6CA12CA2 | |
| SCHEMBL2595163 | 0.81 | MPO (0.62) | TSHRHIF1ACYP2D6CA12CA2 | |
| SCHEMBL28133911 | 0.81 | CA12 (0.74) | TSHRHIF1ACYP2D6CA12CA2 | |
| SCHEMBL28044791 | 0.81 | HIF1A (0.59) | TSHRHIF1ACYP2D6CA12CA2 | |
| SCHEMBL460754 | 0.81 | TSHR (1.00) | TSHRHIF1ACYP2D6CA12CA2 | |
| SCHEMBL8991903 | 0.81 | ALDH1A1 (0.44) | TSHRHIF1ACYP2D6AKR1B1KDM4E | |
| SCHEMBL14793752 | 0.81 | AKR1B1 (0.53) | TSHRHIF1ACYP2D6AKR1B1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5844012-A | Process and composition for improving the cure of water-blown molded polyurethane foam | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1998-12-01 | — | — | US | claimed |
| US-4091088-A | Phenolic amino-carboxylic acid complexes for forming radiopharmaceuticals | AUSTRALIAN ATOMIC ENERGY COMMISSION (AU) | 1978-05-23 | — | — | US | claimed |
| US-4088747-A | Phenolic amino-carboxylic acid radiopharmaceuticals | AUSTRALIAN ATOMIC ENERGY COMMISSION (AU) | 1978-05-09 | — | — | US | claimed |
| JP-11255632-A | — | — | None | — | — | JP | disclosed |
| US-20260132160-A1 | IRON REPLACEMENT TREATMENTS | THE GENERAL HOSPITAL CORP (US) | 2026-05-14 | — | — | US | disclosed |
| EP-4604943-A2 | IRON REPLACEMENT TREATMENTS | The General Hospital Corporation (US) | 2025-08-27 | — | — | EP | disclosed |
| WO-2024086535-A2 | IRON REPLACEMENT TREATMENTS | THE GENERAL HOSPITAL CORPORATION (US) | 2024-04-25 | — | — | WO | disclosed |
| CN-112805312-B | Catalyst for PIR/PUR foam production | 亨茨曼国际有限公司 | 2023-03-21 | — | — | CN | disclosed |
| EP-3848349-B1 | A PROCESS FOR THE PREPARATION OF SALTS OF N,N'-DISUBSTITUTED ETHYLENEDIAMINE-N,N'-DIACETIC ACID DERIVATIVES AND THEIR USE | PRZED PRODUKCYJNO CONSULTINGOWE ADOB SP Z O O (PL) | 2023-03-15 | — | — | EP | disclosed |
| WO-2022148843-A1 | COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE THEREOF | 3B PHARMACEUTICALS GMBH (DE) | 2022-07-14 | — | — | WO | disclosed |
| EP-3848349-A1 | A PROCESS FOR THE PREPARATION OF SALTS OF N,N'-DISUBSTITUTED ETHYLENEDIAMINE-N,N'-DIACETIC ACID DERIVATIVES AND THEIR USE | Przedsiebiorstwo Produkcyjno-Consultingowe ADOB Sp. z o.o. Sp. jawna (PL) | 2021-07-14 | — | — | EP | disclosed |
| US-4256802-A | BLENDING A POLYISOCYANATE AND AN AMINE DIOL MISCIBLE WITH THE FLUOROCARBON BLOWING AGENTS AND TRIMERIZATION CATALYST; LAMINATION; INSULATION | THE UPJOHN COMPANY (US) | 1981-03-17 | — | — | US | disclosed |
| US-4246364-A | USEFUL AS LAMINATES | THE UPJOHN COMPANY (US) | 1981-01-20 | — | — | US | disclosed |
| US-4126742-A | High-modulus polyisocyanurate elastomers | THE UPJOHN COMPANY (US) | 1978-11-21 | — | — | US | disclosed |
| US-4126741-A | High-modulus polyisocyanurate elastomers | THE UPJOHN COMPANY (US) | 1978-11-21 | — | — | US | disclosed |
| US-4011180-A | NOVEL COCATALYST SYSTEM FOR TRIMERIZING POLYISOCYANATES | THE UPJOHN COMPANY (US) | 1977-03-08 | — | — | US | disclosed |
| US-4011180-A | NOVEL COCATALYST SYSTEM FOR TRIMERIZING POLYISOCYANATES | THE UPJOHN COMPANY (US) | 1977-03-08 | — | — | US | disclosed |
| US-3986991-A | EPOXIDES, TERTIARY AMINE, GLYCINE SALT | THE UPJOHN COMPANY (US) | 1976-10-19 | — | — | US | disclosed |
| US-3986991-A | EPOXIDES, TERTIARY AMINE, GLYCINE SALT | THE UPJOHN COMPANY (US) | 1976-10-19 | — | — | US | disclosed |
| US-3903018-A | Novel cocatalyst system for trimerizing polyisocyanates | DOW CHEMICAL COMPANY, THE | 1975-09-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260132160-A1 | IRON REPLACEMENT TREATMENTS | TFRC, SLC40A1, FTH1 | TSHR 39/4885HIF1A 353/4885CYP2D6 1393/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.